Christian B. Dinneen-Long
General Counsel bij GLYCOMIMETICS, INC.
Profiel
Christian B.
Dinneen-Long is currently the Secretary, Vice President & Corporate Counsel at GlycoMimetics, Inc. He previously worked as an Assistant General Counsel at Guilford Pharmaceuticals, Inc., an Associate General Counsel at Emergent BioSolutions, Inc., and a Senior Counsel at Medimmune, Inc. He received his undergraduate degree from the University of Wisconsin and his graduate degree from Chicago-Kent College of Law.
Actieve functies van Christian B. Dinneen-Long
| Bedrijven | Functie | Begin |
|---|---|---|
| GLYCOMIMETICS, INC. | General Counsel | 29-04-2019 |
Eerdere bekende functies van Christian B. Dinneen-Long
| Bedrijven | Functie | Einde |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | General Counsel | - |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | General Counsel | - |
| Medimmune, Inc. | General Counsel | - |
Opleiding van Christian B. Dinneen-Long
| University of Wisconsin | Undergraduate Degree |
| Chicago-Kent College of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
| Medimmune, Inc. | Health Technology |
